Until March 2023, 3,937 cases of mpox or also called monkey smallpox had been identified in Mexico: 315 were under study and there were a total of 19 deaths (18 men and only one woman).
As determined by the Health Secretary, “up to March 20, 19 deaths were identified (18 men and one woman); of which, four are directly related to mpox infection. Two are not related for this reason and 13 are being analyzed by a group of experts in infectious disease and epidemiology to define whether there is a causal association… These are 18 men and one woman, who during medical care presented lesions compatible with monkeypox and that, after the laboratory study, were confirmed”.
The first case was registered in May 2022
In total, in Mexico 6,625 people have been analyzed who meet the operational definition of a problem case, of these three, 3,937 cases have been confirmed with mpox or monkeypox, in addition 2,373 were discarded by laboratory test and four deaths were registered.
The document with all the information is available at viruela.mx. It is reported in said file that, since the registration of the first case in May 2022, and until March 20, 2023, the positive cases are distributed in the 32 federal entities.
Rash occurs in 100% of monkeypox cases
For its part, the Institute of Epidemiological Diagnosis and Reference (InDRE) reported that there are 2,030 infections in CDMX; in Jalisco, 402: State of Mexico, 361; Quintana Roo, 239; Yucatan, 169; Nuevo Leon, 128; Puebla, 68; Veracruz, 65; Tabasco, 57; Chiapas, 52; Lower California, 32; Tamaulipas, 31; Queretaro, 30; Hidalgo, 26, and Morelos, 25.
Regarding the distribution by sex assigned at birth, the predominance is in men, with 97 percent of the cases and the age group between 30 and 34 years is the one with the highest prevalence, with 1,027 of the 3 thousand 937 confirmed cases.
The most common symptoms reported by monkeypox are rash in 100 percent of cases; followed by fever, in 72.1 percent and headaches, in 62.9 percent.